96 related articles for article (PubMed ID: 12097564)
1. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
Ochsenbauer-Jambor C; Delos SE; Accavitti MA; White JM; Hunter E
J Virol; 2002 Aug; 76(15):7518-27. PubMed ID: 12097564
[TBL] [Abstract][Full Text] [Related]
2. Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.
Holmen SL; Melder DC; Federspiel MJ
J Virol; 2001 Jan; 75(2):726-37. PubMed ID: 11134286
[TBL] [Abstract][Full Text] [Related]
3. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.
Earp LJ; Delos SE; Netter RC; Bates P; White JM
J Virol; 2003 Mar; 77(5):3058-66. PubMed ID: 12584331
[TBL] [Abstract][Full Text] [Related]
4. A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses.
Knauss DJ; Young JA
J Virol; 2002 Jun; 76(11):5404-10. PubMed ID: 11991969
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.
Melder DC; Pankratz VS; Federspiel MJ
J Virol; 2003 Oct; 77(19):10504-14. PubMed ID: 12970435
[TBL] [Abstract][Full Text] [Related]
6. Two functionally distinct forms of a retroviral receptor explain the nonreciprocal receptor interference among subgroups B, D, and E avian leukosis viruses.
Adkins HB; Blacklow SC; Young JA
J Virol; 2001 Apr; 75(8):3520-6. PubMed ID: 11264341
[TBL] [Abstract][Full Text] [Related]
7. Soluble receptor-induced retroviral infection of receptor-deficient cells.
Damico R; Bates P
J Virol; 2000 Jul; 74(14):6469-75. PubMed ID: 10864659
[TBL] [Abstract][Full Text] [Related]
8. Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.
Matsuyama S; Delos SE; White JM
J Virol; 2004 Aug; 78(15):8201-9. PubMed ID: 15254191
[TBL] [Abstract][Full Text] [Related]
9. Intronic deletions that disrupt mRNA splicing of the tva receptor gene result in decreased susceptibility to infection by avian sarcoma and leukosis virus subgroup A.
Reinišová M; Plachý J; Trejbalová K; Šenigl F; Kučerová D; Geryk J; Svoboda J; Hejnar J
J Virol; 2012 Feb; 86(4):2021-30. PubMed ID: 22171251
[TBL] [Abstract][Full Text] [Related]
10. Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion.
Côté M; Zheng YM; Liu SL
J Virol; 2009 Nov; 83(22):11447-55. PubMed ID: 19726505
[TBL] [Abstract][Full Text] [Related]
11. Activated vitronectin as a target for anticancer therapy with human antibodies.
Bloemendal HJ; de Boer HC; Koop EA; van Dongen AJ; Goldschmeding R; Landman WJ; Logtenberg T; Gebbink MF; Voest EE
Cancer Immunol Immunother; 2004 Sep; 53(9):799-808. PubMed ID: 15197494
[TBL] [Abstract][Full Text] [Related]
12. Efficient method to optimize antibodies using avian leukosis virus display and eukaryotic cells.
Yu C; Pike GM; Rinkoski TA; Correia C; Kaufmann SH; Federspiel MJ
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9860-5. PubMed ID: 26216971
[TBL] [Abstract][Full Text] [Related]
13. Diverse viral glycoproteins as well as CD4 co-package into the same human immunodeficiency virus (HIV-1) particles.
Gregory DA; Olinger GY; Lucas TM; Johnson MC
Retrovirology; 2014 Apr; 11():28. PubMed ID: 24708808
[TBL] [Abstract][Full Text] [Related]
14. Simple, automated, high resolution mass spectrometry method to determine the disulfide bond and glycosylation patterns of a complex protein: subgroup A avian sarcoma and leukosis virus envelope glycoprotein.
Pike GM; Madden BJ; Melder DC; Charlesworth MC; Federspiel MJ
J Biol Chem; 2011 May; 286(20):17954-67. PubMed ID: 21454567
[TBL] [Abstract][Full Text] [Related]
15. Endogenous expression of ASLV viral proteins in specific pathogen free chicken embryos: relevance for the developmental biology research field.
McNally MM; Wahlin KJ; Canto-Soler MV
BMC Dev Biol; 2010 Oct; 10():106. PubMed ID: 20955591
[TBL] [Abstract][Full Text] [Related]
16. Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.
Edmonds TG; Ding H; Yuan X; Wei Q; Smith KS; Conway JA; Wieczorek L; Brown B; Polonis V; West JT; Montefiori DC; Kappes JC; Ochsenbauer C
Virology; 2010 Dec; 408(1):1-13. PubMed ID: 20863545
[TBL] [Abstract][Full Text] [Related]
17. A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.
Melder DC; Yin X; Delos SE; Federspiel MJ
J Virol; 2009 Sep; 83(17):8575-86. PubMed ID: 19515762
[TBL] [Abstract][Full Text] [Related]
18. Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping.
Jorgenson RL; Vogt VM; Johnson MC
J Virol; 2009 May; 83(9):4060-7. PubMed ID: 19224995
[TBL] [Abstract][Full Text] [Related]
19. Receptor-induced thiolate couples Env activation to retrovirus fusion and infection.
Smith JG; Cunningham JM
PLoS Pathog; 2007 Dec; 3(12):e198. PubMed ID: 18260686
[TBL] [Abstract][Full Text] [Related]
20. Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide.
Amberg SM; Netter RC; Simmons G; Bates P
J Virol; 2006 Jan; 80(1):353-9. PubMed ID: 16352560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
